<bill session="117" type="h" number="8768" updated="2022-12-29T12:18:42Z">
  <state datetime="2022-09-02">REFERRED</state>
  <status>
    <introduced datetime="2022-09-02"/>
  </status>
  <introduced datetime="2022-09-02"/>
  <titles>
    <title type="display">Fighting Cancer in Children Act</title>
    <title type="short" as="introduced">Fighting Cancer in Children Act</title>
    <title type="official" as="introduced">To rescind and transfer funds available for the Office of the Director of the National Institutes of Health to accounts for pediatric cancer research, awareness, and survivorship, to reduce the deficit, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="N000190"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-09-02">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-09-02" state="REFERRED">
      <text>Referred to the House Committee on Appropriations.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSAP" name="House Appropriations" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-13T23:11:13Z" status="Introduced in House">Fighting Cancer in Children Act

This bill makes funding available for research and related activities concerning pediatric cancer that are conducted or supported by the National Institutes of Health (NIH) from funds previously made available to the NIH Office of the Director.

Specifically, the bill transfers unobligated funding from the NIH Office of the Director and merges it with other NIH funding for biorepositories of pediatric cancer specimens and research on pediatric cancer survivorship. The bill also rescinds additional funding that was provided to the NIH Office of the Director.</summary>
</bill>
